• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New protective antigen of group A streptococci.A组链球菌的新型保护性抗原。
J Clin Invest. 1999 May;103(9):1261-8. doi: 10.1172/JCI5118.
2
Spa contributes to the virulence of type 18 group A streptococci.链球菌表面蛋白A有助于18型A组链球菌的毒力。
Infect Immun. 2001 May;69(5):2943-9. doi: 10.1128/IAI.69.5.2943-2949.2001.
3
Recombinant tetravalent group A streptococcal M protein vaccine.重组A群链球菌M蛋白四价疫苗
J Immunol. 1993 Aug 15;151(4):2188-94.
4
Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.链球菌保护性抗原(Spa):A 组链球菌的一种新型型特异性蛋白家族。
Eur J Clin Microbiol Infect Dis. 2010 Jan;29(1):51-7. doi: 10.1007/s10096-009-0819-0. Epub 2009 Oct 29.
5
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.5型链球菌M蛋白氨基末端保护性表位的定位
J Exp Med. 1986 May 1;163(5):1191-202. doi: 10.1084/jem.163.5.1191.
6
Group A streptococcus expresses a trio of surface proteins containing protective epitopes.A组链球菌表达一组含有保护性表位的表面蛋白。
Clin Vaccine Immunol. 2014 Oct;21(10):1421-5. doi: 10.1128/CVI.00448-14. Epub 2014 Jul 30.
7
Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.引发交叉保护性局部免疫反应的A组链球菌M蛋白表位。
J Immunol. 1992 Feb 1;148(3):888-93.
8
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.1型链球菌M蛋白氨基末端区域的序列及型特异性免疫原性
J Immunol. 1987 Nov 1;139(9):3084-90.
9
Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens.化脓性链球菌编码一种67千道尔顿肌球蛋白交叉反应抗原的基因的克隆及序列分析显示其与II类主要组织相容性抗原有相似性。
Infect Immun. 1994 Jun;62(6):2440-9. doi: 10.1128/iai.62.6.2440-2449.1994.
10
Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.抗A组链球菌黏膜定植的合成肽疫苗。I. 针对具有共享C重复区域表位的异源M血清型的保护作用。
J Immunol. 1990 Aug 15;145(4):1251-6.

引用本文的文献

1
A Conserved Streptococcal Virulence Regulator Controls the Expression of a Distinct Class of M-Like Proteins.一种保守的链球菌毒力调节因子控制着 M 样蛋白的一类独特表达。
mBio. 2019 Oct 22;10(5):e02500-19. doi: 10.1128/mBio.02500-19.
2
The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.疫苗对流感后继发性细菌感染的意外影响
Viral Immunol. 2018 Mar;31(2):159-173. doi: 10.1089/vim.2017.0138. Epub 2017 Nov 17.
3
Towards developing a vaccine for rheumatic heart disease.致力于研发一种用于风湿性心脏病的疫苗。
Glob Cardiol Sci Pract. 2017 Mar 31;2017(1):e201704. doi: 10.21542/gcsp.2017.4.
4
Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.局部Th17/IgA免疫与抵抗化脓性链球菌鼻内感染的保护作用相关。
PLoS One. 2017 Apr 17;12(4):e0175707. doi: 10.1371/journal.pone.0175707. eCollection 2017.
5
Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.鉴定在成人和儿童中被B细胞和T细胞均识别的化脓性链球菌保护性疫苗抗原。
Sci Rep. 2016 Feb 25;6:22030. doi: 10.1038/srep22030.
6
Group A streptococcus expresses a trio of surface proteins containing protective epitopes.A组链球菌表达一组含有保护性表位的表面蛋白。
Clin Vaccine Immunol. 2014 Oct;21(10):1421-5. doi: 10.1128/CVI.00448-14. Epub 2014 Jul 30.
7
Disease manifestations and pathogenic mechanisms of Group A Streptococcus.A 组链球菌的疾病表现及致病机制
Clin Microbiol Rev. 2014 Apr;27(2):264-301. doi: 10.1128/CMR.00101-13.
8
Vaccination against rheumatic heart disease: a review of current research strategies and challenges.风湿性心脏病疫苗接种:当前研究策略和挑战的综述。
Curr Infect Dis Rep. 2012 Aug;14(4):381-90. doi: 10.1007/s11908-012-0263-7.
9
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.新型 30 价 M 蛋白疫苗引发针对 A 组链球菌非疫苗血清型的交叉调理抗体。
Vaccine. 2011 Oct 26;29(46):8175-8. doi: 10.1016/j.vaccine.2011.09.005. Epub 2011 Sep 13.
10
Characterization of a new protective antigen of Streptococcus canis.鉴定一株新型犬链球菌保护性抗原。
Vet Res Commun. 2010 Jun;34(5):413-21. doi: 10.1007/s11259-010-9414-1. Epub 2010 May 21.

本文引用的文献

1
ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI.A 组溶血性链球菌型特异性物质的抗原特性。
J Exp Med. 1939 Feb 28;69(3):425-45. doi: 10.1084/jem.69.3.425.
2
Current knowledge of type-specific M antigens of group A streptococci.A组链球菌特定类型M抗原的现有知识。
J Immunol. 1962 Sep;89:307-13.
3
The occurrence of two M antigens in certain group A streptococci related to type 14.某些与14型相关的A群链球菌中两种M抗原的出现。
J Exp Med. 1961 Feb 1;113(2):451-65. doi: 10.1084/jem.113.2.451.
4
Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.多价A群链球菌疫苗,旨在优化六个串联M蛋白片段的免疫原性。
Vaccine. 1999 Jan;17(2):193-200. doi: 10.1016/s0264-410x(98)00150-9.
5
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.透明质酸荚膜和M蛋白对A组链球菌黏液样菌株毒力的相对贡献。
Infect Immun. 1997 Jan;65(1):64-71. doi: 10.1128/iai.65.1.64-71.1997.
6
Recombinant, octavalent group A streptococcal M protein vaccine.重组八价A组链球菌M蛋白疫苗
Vaccine. 1996 Jul;14(10):944-8. doi: 10.1016/0264-410x(96)00050-3.
7
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes.M相关蛋白(Mrp)有助于A组链球菌抵抗人粒细胞的吞噬作用。
Mol Microbiol. 1996 Feb;19(3):429-41. doi: 10.1046/j.1365-2958.1996.377910.x.
8
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.透明质酸荚膜和表面M蛋白在A群链球菌抗调理作用中的作用
Infect Immun. 1996 May;64(5):1495-501. doi: 10.1128/iai.64.5.1495-1501.1996.
9
Recombinant tetravalent group A streptococcal M protein vaccine.重组A群链球菌M蛋白四价疫苗
J Immunol. 1993 Aug 15;151(4):2188-94.
10
Structural heterogeneity of the emm gene cluster in group A streptococci.A群链球菌中emm基因簇的结构异质性
Mol Microbiol. 1993 May;8(4):707-17. doi: 10.1111/j.1365-2958.1993.tb01614.x.

A组链球菌的新型保护性抗原。

New protective antigen of group A streptococci.

作者信息

Dale J B, Chiang E Y, Liu S, Courtney H S, Hasty D L

机构信息

Veterans Affairs Medical Center, Memphis, Tennessee 38104, USA.

出版信息

J Clin Invest. 1999 May;103(9):1261-8. doi: 10.1172/JCI5118.

DOI:10.1172/JCI5118
PMID:10225969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC408353/
Abstract

It is widely believed that the surface M protein of group A streptococci is the predominant surface protein of these organisms containing opsonic epitopes. In the present study, we identified a new surface protein, distinct from M protein, that evokes protective antibodies. A type 18 M-negative mutant was found to be both resistant to phagocytosis in human blood and virulent in mice. The wild-type strain, but not the M-negative mutant, was opsonized by antisera against purified recombinant M18 protein or a synthetic peptide copying the NH2-terminus of M18. However, antisera raised against a crude pepsin extract of the M-negative mutant opsonized both strains, indicating the presence of a protective antigen in addition to type 18 M protein. This antiserum was used to identify and purify a 24-kDa protein fragment (Spa, streptococcal protective antigen) that evoked antibodies that opsonized the M18 parent and the M-negative mutant. The results of passive mouse protection tests confirmed the presence of protective epitopes within Spa. The deduced amino acid sequence of a 636-bp 5' fragment of the spa18 gene showed no homology with sequences in GenBank. These studies reveal the presence of a new protective antigen of certain strains of group A streptococci that may prove to be an important component of vaccines to prevent streptococcal infections.

摘要

人们普遍认为,A 组链球菌的表面 M 蛋白是这些含有调理素表位的微生物的主要表面蛋白。在本研究中,我们鉴定出一种不同于 M 蛋白的新表面蛋白,它能引发保护性抗体。发现一株 18 型 M 阴性突变体对人血中的吞噬作用具有抗性,并且在小鼠中具有致病性。野生型菌株可被抗纯化重组 M18 蛋白或复制 M18 NH2 末端的合成肽的抗血清调理,但 M 阴性突变体则不能。然而,针对 M 阴性突变体的粗胃蛋白酶提取物产生的抗血清可调理这两种菌株,这表明除了 18 型 M 蛋白外还存在一种保护性抗原。该抗血清用于鉴定和纯化一个 24 kDa 的蛋白片段(Spa,链球菌保护性抗原),该片段引发的抗体可调理 M18 亲本菌株和 M 阴性突变体。被动小鼠保护试验结果证实 Spa 内存在保护性表位。spa18 基因 636 bp 5' 片段的推导氨基酸序列与 GenBank 中的序列无同源性。这些研究揭示了 A 组链球菌某些菌株中存在一种新的保护性抗原,这可能被证明是预防链球菌感染疫苗的重要组成部分。